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ated by the action of several different ppGalNAcTs onCellular Addresses:
the same protein backbone without simultaneous sugarStep One in Creating a Glycocode chain initiation at every amino acid that is ultimately
glycosylated [1, 8].
In this issue, the Bertozzi, Gerken, and Tabak groups
report the first systematic study of the in vitro peptideIn this issue of Chemistry & Biology, a library screening
or glycopeptide substrate requirements of eight mem-approach reveals at least four types of enzymes that
bers of the ppGalNAcT family [1]. These groups createdattach galactosamine to build cell surface mucin-type
a library of compounds based on a 13-amino acid seg-glycoproteins [1]. A better molecular understanding of
ment of a rat mucin that includes every possible combi-how these information-carrying oligosaccharides are
nation of sugar-modified threonine residues with up tocreated sets the stage for designing more selective
four galactosamines. This library was incubated withinhibitors and potential therapeutics.
each of eight glycosyltransferase isoforms and uridine-
diphospho-N-azidoacetylgalactosamine (UDP-GalNAz)Cell surfaces are covered in diverse strings and
under saturating conditions. The azide-labeled substratebranches of carbohydrate structures that create a kind
was previously shown to undergo this enzymatic processof three-dimensional address system, or glycocode,
and provided a convenient method to detect the newlywhich mediates interactions with a variety of biological
added sugars after Staudinger ligation with a modifiedcomponents such as proteins or other cells [2, 3]. These
phosphine and standard signal amplification [10].addresses often change as cells grow and differentiate
Analysis of the data reveals four basic types of ppGal-or become diseased [4]. Pathogens such as viruses and
NacTs. Some prefer peptides with no sugars or only onebacteria use such complex sugar structures to adhere
sugar already attached; glycosylation of nearby aminoto tissue for invasion of their hosts. The inhibition or
acids inhibits these so-called early transferases. Thepromotion of these carbohydrate-based interactions
intermediate ppGalNAcTs prefer peptides with two, orserves as a new frontier in therapeutics for the treatment
to a lesser extent, three sugars attached. The late trans-of conditions from cancer to viral and bacterial infec-
ferases glycosylate peptides that already have threetions [5–7]. Unfortunately, very little is known about how
or even four sugars attached nearby. Interestingly, thethese complex codes are assembled and regulated at
enzymes in these three categories have some redundantthe molecular level. In many cases, the actual changes
functions, in that two different transferases will glycosy-to the cell surface architecture that occur with age or
late the same peptide. Therefore, the loss of functiondisease are not even known yet.
of one of these enzymes in vivo can perhaps be rescuedThe most common protein-associated cell surface
in part by other isoforms. In contrast, two of the eightcarriers of glycocodes in humans are the mucins or
tested ppGalNAcTs form a fourth category, which con-mucin-like proteins. O-glycosylation of the protein back-
tains very specialized functions that cannot be takenbone at serine or threonine side chains with N-acetyl-
over by other isoforms. Indeed, the knockout of one ofgalactosamine (GalNAc) followed by addition of various
these latter transferases in a fruit fly is shown to beother sugars creates densely clustered regions of carbo-
lethal [11, 12]; therefore, the effect of a knockout ofhydrates that often eclipse the protein in size. The origi-
the other specialized ppGalNAcT will be of particularnal hypothesis that these carbohydrate chains are initi-
interest. Should the other isoforms prove incapable ofated by only a few polypeptide GalNAc-transferases
rescuing the function of this specialized transferase, the(ppGalNAcTs) is now being replaced with the realization
real power of the molecular approach to mucin biosyn-that the system is far more complex (Figure 1) [8]. The
thesis studies reported in this issue will become ap-human genome contains 24 putative ppGalNAcTs, and
parent.each isoform varies in its spatial and temporal regulation
The next question is if the now known differencesas well as tissue location [9]. A picture is emerging in
which the highly glycosylated mucin domains are cre- in substrate acceptance among these isoforms can be
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plants, fungi, and bacteria and exhibit a wide range ofNovel Mechanism for Priming
biological activities of interest to the pharmaceuticalAromatic Polyketide Synthases industry (antibiotics, anticancer, antifungals, or immu-
nosuppressive agents) and the agrochemical industry
(insecticides or antiparasitic agents) [3]. From simply
looking at the chemical structures of polyketides, thereIn this issue of Chemistry & Biology, a novel priming
are no common structural features to suggest that thesemechanism is proposed for aromatic polyketide bio-
compounds all belong to the same family. However,synthesis, with an iterative type I polyketide synthase
when the various biosynthetic pathways for generatinggenerating a starter unit primed for a type II polyketide
polyketide are considered, it is clear that they share asynthase [6]. This novel priming system participates
common thread: all polyketide biosynthesis involves thein hedamycin biosynthesis, a DNA alkylating agent.
assembly of carbon chains from acyl precursors in a
series of reactions catalyzed by a complex enzymaticMany natural products are bioactive, and polyketides
system, the polyketide synthase (PKS). The reaction be-constitute one of the most important families of natural
products [1, 2]. Polyketides are widely distributed in gins when PKS is primed by a starter molecule and then
